Discoordinate gene expression of aggrecan and type ii collagen in experimental osteoarthritis

John R. Matyas, Mark E. Adams, Dingqiu Huang, Linda J. Sandell

Research output: Contribution to journalArticle

70 Scopus citations

Abstract

Objective. To quantify the gene expression of aggrecan core protein and type II collagen in an experimental animal model of osteoarthritis (OA). Methods. Total RNA was extracted from the articular cartilage of unoperated knee joints and from OA joints produced by anterior cruciate ligament transection. The relative amounts of type II collagen and aggrecan core protein messenger RNA (mRNA) were evaluated by Northern blot analysis. Results. Total RNA was elevated 2.5 times, aggrecan mRNA was elevated 2 times, and type II collagen mRNA was elevated 8 times, in OA knees compared to unoperated controls. Conclusion. Chondrocytes are activated metabolically in response to joint injury. Discoordinate gene expression of aggrecan and type II collagen is characteristic of early experimental OA, and we speculate that it may contribute to its pathogenesis.

Original languageEnglish
Pages (from-to)420-425
Number of pages6
JournalArthritis & Rheumatism
Volume38
Issue number3
DOIs
StatePublished - Mar 1995

Fingerprint Dive into the research topics of 'Discoordinate gene expression of aggrecan and type ii collagen in experimental osteoarthritis'. Together they form a unique fingerprint.

  • Cite this